Micelle BioPharma has a total of 40 patents globally, out of which 17 have been granted. Of these 40 patents, more than 15% patents are active. United States of America is where Micelle BioPharma has filed the maximum number of patents, followed by Mexico and Europe (EPO). Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Micelle BioPharma.
Micelle BioPharma, rebranded in 2019 from Sancilio & Company (founded in 2005), is a pharmaceutical company specializing in the development and commercialization of products using its proprietary Advanced Lipid Technologies® (ALT®) platform. This drug delivery system enhances the absorption and effectiveness of lipophilic compounds such as fatty acids, vitamins, hormones, and APIs. In addition to developing proprietary pharmaceutical products, Micelle provides product development, soft gel manufacturing, and contract sales services, while maintaining strong ties with its local community.
Do read about some of the most popular patents of Micelle BioPharma which have been covered by us in this article and also you can find Micelle BioPharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Micelle BioPharma patent portfolio.
How many patents does Micelle BioPharma have?
Micelle BioPharma has a total of 40 patents globally. These patents belong to 4 unique patent families. Out of 40 patents, 6 patents are active.
How Many Patents did Micelle BioPharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Micelle BioPharma Applications Filed | Micelle BioPharma Patents Granted |
| 2022 | – | 1 |
| 2021 | – | 1 |
| 2020 | – | 4 |
| 2019 | – | 5 |
| 2018 | – | 3 |
| 2017 | 6 | 2 |
| 2016 | 4 | 1 |
| 2015 | 5 | – |
| 2014 | 6 | – |
| 2013 | 18 | – |
| 2009 | 1 | – |
How many Micelle BioPharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Micelle BioPharma File in Different Countries?
Countries in which Micelle BioPharma Filed Patents
| Country | Patents |
| United States of America | 8 |
| Mexico | 3 |
| Europe (EPO) | 2 |
| Austria | 2 |
| India | 2 |
| Malaysia | 1 |
| Korea (South) | 1 |
| South Africa | 1 |
| Croatia | 1 |
| Spain | 1 |
| Denmark | 1 |
| Germany | 1 |
| Saudi Arabia | 1 |
| Portugal | 1 |
| Japan | 1 |
| Russia | 1 |
| Australia | 1 |
| Israel | 1 |
| Africa | 1 |
| Brazil | 1 |
| Chile | 1 |
| Norway | 1 |
| China | 1 |
| Hong Kong (S.A.R.) | 1 |
| Colombia | 1 |
| Canada | 1 |
Where are Research Centres of Micelle BioPharma Patents Located?
Micelle BioPharma Best Patent
WO2013148136A1 is the most popular patent in the Micelle BioPharma portfolio. It has received 130 citations so far from companies like Amarin Pharmaceuticals Ireland and Afimmune Limited.
List of Micelle BioPharma Patents
| Micelle BioPharma Patents | Title |
| MY189576A | Omega-3 Fatty Acid Ester Compositions |
| IN381456B | Omega 3 Fatty Acid Ester Compositions |
| AT1325134T | Omega-3 Fatty Acid Ester Compositions |
| ES2741560T3 | Compositions Of Esters Of Omega-3 Fatty Acids |
| ZA201702385B | Self-Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States |
| KR102193214B1 | Omega-3 Fatty Acid Ester Compositions |
| MX2020002238A | Self-Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States. |
| EP3072510B1 | Omega-3 Fatty Acid Ester Compositions |
| HRP20191392T1 | Omega-3 Fatty Acid Ester Compositions |
| DK3072510T3 | Omega-3 Fatty Acid Ester Compositions |
| AT1129077T | Omega-3 Fatty Acid Ester Compositions |
| DE602013055307T2 | Omega-3 Fatty Acid Ester Compositions |
| PT3072510T | Omega-3 Fatty Acid Ester Compositions |
| SA517381254A | Self-Appearing Fatty Acids And Fatty Acid Ester Formulations And Their Use In The Treatment Of Pathological Conditions |
| MX359711B | Omega-3 Fatty Acid Ester Compositions. |
| IL234814B | Omega-3 Fatty Acid Ester Compositions |
| JP6359517B2 | Omega-3 Fatty Acid Ester Composition |
| RU2633862C2 | Compositions Of The Complexes Of Omega-3 Fatty Acids |
| AU2013240427B2 | Omega-3 Fatty Acid Ester Compositions |
| EP3212236A1 | Self-Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States |
| APP2017009851A0 | Self-Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States |
| BR112017007428A2 | Fatty Acid Ester Compositions And Self-Commonizing Fatty Acids And Their Uses In The Treatment Of Disease States |
| CL201700867A1 | Compositions Of Self-Forming Micelle Fatty Acids And Fatty Acid Esters And Their Use In The Treatment Of Pathologies |
| IN201717015828A | Self Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States |
| MX2017004324A | Self-Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States. |
| NO3072510B1 | Omega-3 Fatty Acid Ester Compositions |
| US20160296492A1 | Self-Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States |
| US20160235853A1 | Omega-3 Fatty Acid Ester Compositions |
| US20160228397A1 | Omega-3 Fatty Acid Ester Compositions |
| US20160228398A1 | Omega-3 Fatty Acid Ester Compositions |
| WO2016057915A1 | Self-Micellizing Fatty Acids And Fatty Acid Ester Compositions And Their Use In The Treatment Of Disease States |
| US20150132389A1 | Omega-3 Fatty Acid Ester Compositions |
| US20150125529A1 | Omega-3 Fatty Acid Ester Compositions |
| US20150125530A1 | Omega-3 Fatty Acid Ester Compositions |
| CN104321053A | Omega-3 Fatty Acid Ester Compositions |
| HK1204978A | Omega-3 Fatty Acid Ester Compositions |
| CO7121328A2 | Omega -3 Fatty Acid Ester Compositions |
| WO2013148136A1 | Omega-3 Fatty Acid Ester Compositions |
| CA2867168A1 | Omega-3 Fatty Acid Ester Compositions |
| US20100278913A1 | Chewable Tablet |
What are Micelle BioPharma key innovation segments?
What Technologies are Covered by Micelle BioPharma?
The chart below distributes patents filed by Micelle BioPharma in different countries on the basis of the technology protected in patents. It also represents the markets where Micelle BioPharma thinks it’s important to protect particular technological inventions.
R&D Focus: How has Micelle BioPharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Micelle BioPharma?
